CVSL Inc. (CVSL: OTCQX U.S.) | CVSL Announces Two

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CVSL Inc. (CVSL: OTCQX U.S.) | CVSL Announces Two Additional Directors Roy G. C. Damary And Dr. Bernard Ivaldi Elected To Board CVSL Announces Two Additional Directors Roy G. C. Damary And Dr. Bernard Ivaldi Elected To Board

CVSL Announces Two Additional Directors Roy G. C. Damary And Dr. Bernard Ivaldi Elected To Board

PR Newswire

DALLAS , July 11, 2014 /PRNewswire/ --  CVSL Inc. [OTC QX: CVSL] announced today that Roy G.C. Damary and Dr. Bernard Ivaldi have agreed to serve on the company's board of directors.  They were elected by the board on July 9 .

"We are delighted that Roy Damary and Bernard Ivaldi will be bringing their long and distinguished international experience in business and academia to CVSL's board of directors, particularly their understanding of the dynamics of global commerce," said John Rochon , CVSL's Chairman.  "Adding these two distinguished leaders to our board reinforces CVSL's strategy of being a company with broad international expertise."

Roy G.C. Damary :

Mr. Damary combines a wide range of academic activities with global business experience.  He began his professional career as a research engineer and then techno-economic specialist at the Battelle Institute in Geneva , Switzerland.  From 1984 to 1994 he created and headed the MBA program at Webster University's Geneva campus. 

He is President of the INSAM Foundation in Geneva ; head of business studies at Robert Kennedy College, Switzerland ; and is honorary professor at the Ural State Forest Engineering University of Ekaterinburg, Russia .

He owns Technomic Consultants SA, which provided industrial marketing consultancy for 25 years before its reorientation to management services for foreign-owned Swiss companies.  Mr. Damary is a British citizen residing in Geneva .  He is a member of the board of directors of CVSL AG and JRJR AG, in Luzern, Switzerland .

He holds an M.A. in Engineering Science with First Class Honours from Oxford University (1966), an M.B.A. with High Distinction (Baker Scholar) from Harvard Business School (1974) and a Ph.D. from Lausanne University (2000).

Bernard Ivaldi , Ph.D.:

Dr. Ivaldi has for more than 40 years held a variety of senior positions in business, law and academia in the United States and Europe. 

A French citizen and a resident of Switzerland , Dr. Ivaldi serves as chairman of Tatiana Faberge SA ( Switzerland ); he has served as chairman of Laboratories Helvetica Pharma SA ( Switzerland ); administrator of Lalive & Partners Attorneys at Law ( Switzerland ); director of Webster University in Geneva, Switzerland ; and director general of The International School of Geneva .

Dr. Ivaldi has traveled extensively, lecturing and assisting at international conferences.  He has broad experience in the fields of administration, financial management, personnel management and training.  He serves on several governing boards and has organized many conferences and seminars. 

He has participated in numerous evaluations and accreditations of schools, universities and educational institutions in the United States , Europe and Russia.  He is a former chairman of the International Schools Association, an international NGO with consulting status to UNESCO and ECOSOC.  

In 1994 he founded BI Conseil and Associates, specializing in the audit of corporations and educational institutions, company management and financial and human resources.

For the past 20 years he has consulted extensively with multinational companies and educational institutions in Europe , the United States , South America and Australia.  He served as director general of the Neuromedia Group SA in Belgium , which consists of multimedia companies providing interactive solutions.  He is currently president of FEBP, a Swiss foundation promoting business ethics.  He is a member of the boards of CVSL AG and JRJR AG in Luzern, Switzerland .

Dr. Ivaldi is fluent in French, Italian and English.  He earned a Ph.D. degree from Columbia Pacific University and was a Doctoral Fellow in bilingual education at New York University.  He was awarded a Maitrise de Linguistique Generale (honors) by the University of Nice, France. 

About CVSL

CVSL ( www.cvsl.us.com ) is a growing group of micro-enterprise companies that connect social media networks into an ever-expanding virtual "community" of social commerce. CVSL companies currently include The Longaberger Company , a 40-year old maker of hand-crafted baskets and other home decor items; Your Inspiration At Home , an award-winning maker of hand-crafted spices and other gourmet food items from around the world; Tomboy Tools , a direct seller of tools designed for women as well as home security systems; Agel Enterprises , a global seller of nutritional products in gel form as well as a skin care line sold under the Ageless brand, operating in 40 countries; Paperly , which offers a line of custom stationery and other personalized products; My Secret Kitchen , a U.K.-based seller of gourmet food products; and Uppercase Living , which offers an extensive line of customizable vinyl expressions for display on walls in the home.  In addition, CVSL and Golden Girls , a purchaser of gold and tradable jewelry, have signed a definitive purchase agreement, which is subject to customary closing conditions.

Cautionary Note Regarding Forward-Looking Statements:

This press release contains forward-looking statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this press release are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," or "will" or the negative of these terms or other comparable terminology. Such statements include statements regarding the expected contribution of Messrs. Damary and Ivaldi Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only expectations and involve known and unknown risks, uncertainties, and other factors outlined under "Risk Factors" in our Annual Report on Form 10-K for our fiscal year ended December 31, 2013 , our Quarterly Reports on Form 10-Q, including the Quarterly Report filed with the Securities and Exchange Commission  for the quarter ended March 31, 2014 , and those risks discussed in other documents we file with the Securities and Exchange Commission, which may cause our actual results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements to differ materially from expectations.  Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this press release to conform our statements to actual results or changed expectations.

CVSL Media Contact :  Russell Mack ( rmack@cvsl.us.com ) 

CVSL Investor Relations Contact :  Scott Pumper ( scottp@cvsl.us.com )

SOURCE CVSL Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 81

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 178

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 135

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 88

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 95

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 189

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion180 Unveils Innovative Customizable Flood Insurance

Updated Category News Views 177

Orion180 Launches Customizable Residential Flood Insurance Orion180 is making waves in the insurance sector by introducing its latest offering: a Residential Private Flood Insurance product designed to meet a variety of homeowner needs. Based in Melbourne, this innovative insurance leader is set to change how we approach flood insurance with a product that emphasizes...

Continue Reading
DIFD AUTO Revolutionizes Global Car Buying with Crypto Payments

Updated Category News Views 306

Transforming the Car Buying Experience with Cryptocurrency Today, as the digital landscape continues to evolve, DIFD AUTO stands at the forefront of a revolutionary shift in how consumers purchase vehicles. As a leading platform for cryptocurrency-based car transactions, DIFD AUTO allows customers around the globe to purchase brand-new, certified cars using major...

Continue Reading
Curtiss-Wright Reports Impressive Q3 Results and Outlook Boost

Updated Category News Views 102

Curtiss-Wright's Positive Financial Performance Curtiss-Wright Corporation (NYSE: CW) is a well-known global company recognized for providing highly engineered products and services. Recently, the company reported noteworthy financial results for the third quarter. The sales surged nearly 10% year-over-year, coming close to $800 million, with exceptional growth especially...

Continue Reading
Darling Ingredients Reports Q3 2024 Results Amid Challenges

Updated Category News Views 312

Third Quarter 2024 Overview Darling Ingredients Inc. today reported net income of $16.9 million, or $0.11 per diluted share for the third quarter of 2024. This represents a significant decline compared to net income of $125.0 million, or $0.77 per diluted share, in the third quarter of 2023. The notable decrease in net income is attributed to lower fat prices and reduced...

Continue Reading
Investigation Launched for Investors of Spyre Therapeutics, Inc.

Updated Category News Views 127

Investigation Launched into Spyre Therapeutics, Inc. Pomerantz LLP has announced an investigation on behalf of investors of Spyre Therapeutics, Inc., known by its stock ticker, NASDAQ: SYRE. This inquiry stems from allegations that the company, along with some of its executives and board members, may have been involved in securities fraud or engaged in other unlawful...

Continue Reading